St. Jude Children’s Research Hospital scientists have identified the disease process that underlies Aicardi-Goutières syndrome, a debilitating illness with no known cure.
St. Jude scientists found that a DNA repair system breakdown is to blame for Aicardi-Goutières syndrome (AGS).
St. Jude and the European Working Group of MDS in Childhood report results of a landmark study of the blood disorders known as pediatric myelodysplastic syndromes.
St. Jude scientists worked with researchers in Europe to learn how they might be able to manipulate SAMD9 and SAMD9L genes to the advantage of the patients.
The chair of St. Jude Pharmacy/Pharmaceutical Sciences will receive 2 top science honors from ACCP at its annual meeting. It is highly unusual for both to be presented to the same person in the same year.
Shannon Dean to help oversee launch of hospital’s new electronic health record as the hospital enhances the patient experience.
Findings from St. Jude Children’s Research Hospital show how control of transcription factors by a common tumor suppressor gene may provide a therapeutic opportunity in a type of childhood cancer.
Findings from St. Jude Children’s Research Hospital shed light on what drives this metabolic disease and provides clues to targeted treatment with pantazines.
St. Jude scientists have revealed a previously unknown role for CTCF, a pivotal transcription regulator linked to cancer.
St. Jude scientists detail how inflammasomes act as integral components of mega-cell death complexes called PANoptosomes for host defense in live viral and bacterial infections.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.